PDCD1 and cervical carcinoma: The Efficacy and Safety of BCD-100 (Anti-PD-1) in Combination With Platinum-Based Chemotherapy with and without Bevacizumab as First-Line Treatment of Subjects with Advanced Cervical Cancer, (FERMATA) trial, is a phase III trial combining paclitaxel, platinum-based chemotherapy and an anti-PD-1 (BCD-100) with or without bevacizumab as first line therapy (40).